• Title/Summary/Keyword: Pharmaceutical Society of Korea

Search Result 10,560, Processing Time 0.04 seconds

THE EFFECT OF COPROPHAGY ON THE EXPRESSION OF HEPATIC CYP2E1 DURING STARVATION

  • Chung, Hye-Chin;Sung, Sang-Hyun;Kim, Jin-Soo;Kim, Young-Choong;Kim, Sang-Geon
    • Proceedings of the Korean Society of Toxicology Conference
    • /
    • 2001.05a
    • /
    • pp.141-141
    • /
    • 2001
  • Starvation stimulates multiple signaling pathways, which lead to extensive metabolic alterations Starvation potentiates the hepatotoxicity of a variety of small molecules including chlorinated hydrocarbons and nitrosamines through the induction of CYP2E1. A change in CYF2E1 expression during starvation may also alter the pharmacokinetic profiles of xenobiotics.(omitted)

  • PDF

Studies on the Cytotoxic Constituent of Alnus hirsuta$(S_{PACH})\;R_{UPR}$ (산오리나무의 세포독성 성분연구)

  • Bae, Choon-Il;Gong, Jae-Myung;Oh, Jung-Wan;Kim, Hyun-Jong;Oh, Gab-Jin;Park, Si-Kyung;Chung, Sun-Gan;Cho, Eui-Hwan
    • YAKHAK HOEJI
    • /
    • v.41 no.5
    • /
    • pp.559-564
    • /
    • 1997
  • To find out antitumor active principles from natural resources, we have evaluated various extracts from the leaves of Alnus hirsuta (Betulaceae). The ethylacetate extract of this plant was found to show a significant cytotoxicity against several kinds of cultured human solid tumor cell lines (AGS, A5 49, HCT15, SKOV3, HEP3B) in vitro. Using cytotoxicity-guided chromatographic purification of the ethylacetate extract, cytotoxic constituent:1,7-bis-(4-hydroxyphenyl)-5-(${\beta}$-D-glucopyranosyloxy)-3-heptanone, was isolated and structurally identified by physico-chemical properties and spectroscopic evidences.

  • PDF

Potent inhibition of Lipopolysaccharide-Inducible Nitric Oxide Synthase Expression by Dibenzylbutyrolactone Lignans through Inhibition of I-kB Phosphorylation and of p65 Nuclear Translocation in Macrophages

  • Cho, Min-Kyung;Park, Jung-Won;Jang, Young-Pyo;Kim, Young-Choong;Kim, Sang-Geon
    • Proceedings of the Korean Society of Toxicology Conference
    • /
    • 2001.05a
    • /
    • pp.139-139
    • /
    • 2001
  • Arctigenin and demethyltraxillagenin, dibenzylbutyrolactone lignans, are phenylpropanoid plant metabolites with antioxidative and anti-inflammatory activities. The effects of arctigenin and demethyltraxillagenin on the nuclear factor-kB (NF-kB)-mediated inducible nitric oxide synthase (iNOS) gene expression were studied in Raw264.7 cells.(omitted)

  • PDF

Inhibitory Effects of the Seeds of Cornus officinalis on AGEs Formation and AGEs-induced Protein Cross-linking (산수유 씨의 최종당화산물의 형성 및 교차결합에 미치는 효과)

  • Kim, Chan-Sik;Jang, Dae-Sik;Kim, Jung-Hyun;Lee, Ga-Young;Lee, Yun-Mi;Kim, Young-Sook;Kim, Jin-Sook
    • Korean Journal of Pharmacognosy
    • /
    • v.39 no.3
    • /
    • pp.249-254
    • /
    • 2008
  • An 80% EtOH extract and the solvent fractions of the seeds of Cornus officinalis were evaluated for their inhibitory activities against advanced glycation end products (AGEs) formation and AGEs-induced protein cross-linking in vitro. In vitro assay for AGEs-bovine serum albumin (BSA) formation showed that the 80% EtOH extract, n-hexane, EtOAc, n-BuOH and water fractions significantly inhibited AGEs formation with observed $IC_{50}$ values of 1.13, 17.64, 1.52, 1.24 and $3.27{\mu}g/ml$, respectively. In indirect AGEs-ELISA assay, the 800% EtOH extract, EtOAc and n-BuOH fractions exhibited more potent inhibitory activity on AGEs-BSA formation than aminoguanidine, a well know AGEs inhibitor. Furthermore, the 80% EtOH extract and all the solvent fractions inhibited concentration-dependently AGE-BSA cross-linking to collagen. The 80% EtOH extract, EtOAc, n-BuOH and water fractions also had a breaking activity against preformed AGE-BSA cross-linking concentration dependently. Thus these results suggest that the 80% EtOH extract and fractions of the seeds of C. officinalis could be an inhibitor as well as breaker of AGE-BSA cross-linking.

Screening of Korea Traditional Herbal Medicines with Inhibitory Activity on Advanced Glycation End Products (AGEs) Formation (한약재의 최종당화산물 생성저해활성 검색)

  • Jang, Dae-Sik;Lee, Yun-Mi;Kim, Young-Sook;Kim, Jin-Sook
    • Korean Journal of Pharmacognosy
    • /
    • v.37 no.1 s.144
    • /
    • pp.48-52
    • /
    • 2006
  • Advanced glycation end products (AGEs) are largely involved in the pathogenesis of diabetic complications. As part of our ongoing project directed toward the discovery of preventive and/or delay agents for diabetic complications from natural sources, 92 Korean traditional herbal medicines have been investigated with an in vitro evaluation system using AGEs inhibitory activity. Of these, 17 herbal medicines exhibited a significant inhibitory activity against AGEs formation. Particularly, 9 herbal medicines, i.e., Cinnamomi Cortex, Artemisiae Argyi Herba, Ammoni Tsao-ko Fructus, Menthae Herba, Amomi Semen, Polygoni Avicularis Herba, Lycopi Herba, Salviae Radix, and Nelumbinis Semen showed more potent inhibitory activity (2-4 fold) than the positive control aminoguanidine.

A New Coumestan Glucoside from Eclipta prostrata

  • Seo, Young Ju;Kil, Hyun Woo;Rho, Taewoong;Yoon, Kee Dong
    • Natural Product Sciences
    • /
    • v.26 no.4
    • /
    • pp.289-294
    • /
    • 2020
  • Eclipta prostrata is an annual herb, belonging to Asteraceae family, and has been traditionally used to improve immunity and treat hepatitis and bacterial disease in Korea. In this study, a new coumestan glucoside (1) along with ten known compounds (2 - 11) was isolated from E. prostrata. The chemical structures of isolates were elucidated to be wedelolactone-9-O-β-D-glucopyranoside (1), wedelolactone (2), demethylwedelolactone (3), apigenin (4), apigenin-7-sulfate (5), luteolin (6), luteolin-7-sulfate (7), luteolin-7-O-β-D-glucopyranoside (8), pratensein-7-O-β-D-glucopyranoside (9), 3,4-di-O-caffeoylquinic acid (10) and 3,5-di-O-caffeoylquinic acid (11) based on the spectroscopic evidence.

A Study on the Comparison of Korea GMP with PIC/S GMP for Enhancing International Competecy of Medicinal Product Quality (의약품의 국제적 품질 경쟁력 확보를 위한 의약품실사상호협력기구(PIC/S)와 한국의 GMP 비교연구)

  • Kim, Jeong Yeon;Kwon, Kyenghee
    • YAKHAK HOEJI
    • /
    • v.57 no.6
    • /
    • pp.432-441
    • /
    • 2013
  • It's been almost 20 years since the adoption of Good Manufacturing Practices (GMP) in Korea since 1994. There have been big progresses in the GMP regulations and its implementations. 'New GMP' in 2008 has adopted validation, pre-approval GMP evaluation, annual quality review, etc.. Upon the submission of PIC/S (Pharmaceutical Inspection Cooperation Scheme) application by Korea's Ministry of Food and Drug Safety in April, 2012, Korea is facing new opportunity to level up Korea GMP regulations. As such, this study suggested GMP revision points by comparing and analyzing the differences between PIC/S GMP and Korea GMP. Those areas which GMP is not required such as radiopharmaceuticals and medical gases should adopt GMP. And independent GMP regulation is needed for Active Pharmaceutical Ingredients and investigational medicinal products. Also, those regulations shall be implemented in the higher level of legal status. Finally, rather than pursuing GMP harmonization only for PIC/S membership, GMP improvement in the long term shall be taken into consideration by reflecting current quality issues such as ICH Q8 (Pharmaceutical development), Q9 (Quality Risk Management) and Q10 (Pharmaceutical Quality System).